Platform Preview
About Cervolve
Pioneering Lipid Neurobiology
Cervolve is dedicated to decoding how lipids shape the human brain, turning an underexplored layer of neurobiology into new therapeutic strategies for neurodegenerative disease.
The Brain's Dark Matter
These molecules regulate core mechanisms of neurodegeneration. We transform complex lipid biology into actionable therapeutic targets across disease-relevant pathways.
Team
Co-Founder, CEO
LinkedInA neuroscientist with over 12 years of experience in genetics and lipid biology. His research has directly led to a clinical trial for a lipid function modulator. He has authored 10 first-author publications in top-tier journals.
Co-Founder, CTO
LinkedInAn AI scientist with 8 years of experience in applied AI for life sciences. He earned his PhD at McGill University & Mila, where he developed state-of-the-art AI models for multi-omics and biological data integration.
News
Cervolve has been named one of 20 Discovery Award teams selected from nearly 100 applicants worldwide. The award provides GBP 100,000 in funding and access to one of the largest ALS datasets assembled, including genomics and multi-omics data.
The broader Longitude Prize on ALS will award GBP 7.5M through 2031 to accelerate patient-scale, multimodal discovery for neurodegenerative disease.
From Data to Therapeutics
Our frontier AI model integrates multi-omics data, including genomics, transcriptomics, and imaging, to map lipid pathways across every biological scale of the brain.
Anchored in human genetics, our approach identifies new actionable sites on known targets and stratifies patients to accelerate the path toward clinical success.
Cervolve brings together world-class neuroscience research with cutting-edge AI expertise from Mila, combining more than 12 years of brain science with modern foundation-model development.
Pioneering a new era of lipid neurobiology for neurodegeneration